Why Global Investors of Zoom and Treasure Data Invested in bitBiome: Special Bio×AI Interview Series Launched on 'note'

bitBiome Inc. (Headquarters: Shinjuku, Tokyo; CEO: Yuji Suzuki), a biomanufacturing company, has announced the receipt of investment from several global investors in the third close of its seed extension round. To mark this occasion, the company is launching a series of interview articles on its official 'note' account featuring these investors.

The first interview features IT-Farm Corporation, a venture capital firm known for its early investments in Zoom and Treasure Data. The discussion explores why global investors chose bitBiome and examines the company's potential within the rapidly growing 'Bio×AI' field. Participants from IT-Farm include CEO Kurosaki, General Partner Kasuga, and Silicon Valley-based General Partner Julien Nguyen, who previously led an investment in Twist Bioscience.

### Background: The Global Shift Toward 'Bio × AI' In 2026, AI evolution has entered the 'Applied AI' phase. The utilization of AI in biology (Bio×AI) has moved beyond a temporary buzz to become a global megatrend. bitBiome has utilized its proprietary 'microbial single-cell genome analysis technology' to tap into the world's largest unused resource—microbial genomic data—building one of the world's most extensive databases. The company is now leveraging this massive data asset to aggressively develop its proprietary genome biology model, 'SENS-AI'.

### bitBiome's 'Global Path to Victory' from an Investor's View What led IT-Farm, known for its rigorous selection process in the global investment landscape, to invest in bitBiome? This interview unravels bitBiome's potential for global success from the realistic and objective perspective of investors who monitor the frontlines of the global market. Readers can gain insight into the future bitBiome envisions at the frontier where cutting-edge AI trends and biotechnology intersect.

### About bitBiome Inc. bitBiome is a biomanufacturing company dedicated to unlocking the potential of microbes to shape the future of the bioeconomy. Based on its unique 'bit-MAP®︎' technology, the company has realized 'bit-GEM,' a microbial database containing over 3 billion sequences. By utilizing bioinformatics, machine learning, and AI, bitBiome's platform enables the rapid development and affordable manufacturing of bio-derived products through comprehensive enzyme discovery and metabolic pathway design.